In the financial year 2018/19, we achieved consolidated sales of CHF 453.8 million (previous year: CHF 466.1 million). Compared to the previous year, there was only a slight decline in sales of only 2.7 % despite the termination of the mylife™ OmniPod® business. In continuing operations, we achieved a sales growth of CHF 68.4 million, which represents an increase of 24 %.
The operating result (EBIT) amounted to CHF 73.3 million (previous year: CHF 61.1 million). This includes CHF 49.8 million in revenue and profit-related compensation from Insulet Corp. for the development of the European distribution structure for the Omnipod®. Profitability at EBIT level thus amounted to 16.2 % (previous year: 13.1 %). Net profit for the 2018/19 financial year amounts to CHF 60.1 million (previous year: CHF 52.1 million).
Download reports and fact sheets
On this page you can download all financial publications of Ypsomed Holding AG covering the last five years of business activity. If you prefer a printed copy, please use the order form on this page.